QP 16 - Lung Quick Pitch: Locally Advanced NSCLC

Presentations

• 05:00pm - 05:05pm ET

  Introduction

  Speaker: Joseph Miccio, MD - Penn State Hershey Medical Center, Hershey
• 05:05pm - 05:10pm ET

  Phase III Trial to Compare Weekly and Triweekly Usage of Docetaxel and Cisplatin in Concurrent Chemoradiotherapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

  Speaker: Dan Yang, MD - Beijing Cancer Hospital, Beijing
• 05:10pm - 05:15pm ET

  Coronary Artery Calcifications and Major Adverse Cardiac Events after Radiation Therapy for Locally-Advanced Non-Small Cell Lung Cancer

  Speaker: Christopher Kelsey, MD, FASTRO - Duke University Medical Center, Durham
• 05:15pm - 05:20pm ET

  Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II-III NSCLC

  Speaker: Judi van Diessen, MD, PhD - NKI-AvL, Amsterdam
• 05:20pm - 05:25pm ET

  Risk Classifier for Treatment of Stage III Non-Small Cell Lung Cancer Using Competing Event Regression: Ancillary Analysis of RTOG 0617

  Speaker: Ryan Morse, MD - University of Kansas Medical Center, Kansas City
• 05:25pm - 05:30pm ET

  Predictors of Failure to Undergo Planned Resection after Neoadjuvant Chemoimmunotherapy for LA-NSCLC

  Speaker: Julian McDonald, BA - Perelman School of Medicine at the University of Pennsylvania, Philadelphia
• 05:30pm - 05:35pm ET

  Peripheral PD-1?CD8? T-cell TCR Dynamics during Radiotherapy Predict Survival in Unresectable Locally Advanced Non-Small Cell Lung Cancer

  Speaker: Ying Jiang, MD - Peking Union Medical College Hospital, Beijing
• 05:35pm - 05:55pm ET

  Questions and Answers

  Speaker: Nitin Ohri, MD, MS - Albert Einstein College of Medicine, Bronx
• 05:55pm - 06:00pm ET

  Closing

  Speaker: Joseph Miccio, MD - Penn State Hershey Medical Center, Hershey